These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 33678606)

  • 1. Differential and longitudinal immune gene patterns associated with reprogrammed microenvironment and viral mimicry in response to neoadjuvant radiotherapy in rectal cancer.
    Wilkins A; Fontana E; Nyamundanda G; Ragulan C; Patil Y; Mansfield D; Kingston J; Errington-Mais F; Bottomley D; von Loga K; Bye H; Carter P; Tinkler-Hundal E; Noshirwani A; Downs J; Dillon M; Demaria S; Sebag-Montefiore D; Harrington K; West N; Melcher A; Sadanandam A
    J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33678606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoadjuvant chemoradiation alters biomarkers of anticancer immunotherapy responses in locally advanced rectal cancer.
    Seo I; Lee HW; Byun SJ; Park JY; Min H; Lee SH; Lee JS; Kim S; Bae SU
    J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33692216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptomic Analyses of Pretreatment Tumor Biopsy Samples, Response to Neoadjuvant Chemoradiotherapy, and Survival in Patients With Advanced Rectal Cancer.
    Akiyoshi T; Wang Z; Kaneyasu T; Gotoh O; Tanaka N; Amino S; Yamamoto N; Kawachi H; Mukai T; Hiyoshi Y; Nagasaki T; Yamaguchi T; Konishi T; Fukunaga Y; Noda T; Mori S
    JAMA Netw Open; 2023 Jan; 6(1):e2252140. PubMed ID: 36662520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of Poor Response to Neoadjuvant Chemoradiation in Patients With Rectal Cancer Using a DNA Repair Deregulation Score: Picking the Losers Instead of the Winners.
    Jimenez L; Perez RO; São Julião GP; Vailati BB; Fernandez LM; Gama-Rodrigues J; Habr-Gama A; DeVecchio J; Kalady MF; Camargo AA
    Dis Colon Rectum; 2020 Mar; 63(3):300-309. PubMed ID: 31842156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression profile can predict pathological response to preoperative chemoradiotherapy in rectal cancer.
    Nishioka M; Shimada M; Kurita N; Iwata T; Morimoto S; Yoshikawa K; Higashijima J; Miyatani T
    Cancer Genomics Proteomics; 2011; 8(2):87-92. PubMed ID: 21471518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural killer-like signature observed post therapy in locally advanced rectal cancer is a determinant of pathological response and improved survival.
    Alderdice M; Dunne PD; Cole AJ; O'Reilly PG; McArt DG; Bingham V; Fuchs MA; McQuaid S; Loughrey MB; Murray GI; Samuel LM; Lawler M; Wilson RH; Salto-Tellez M; Coyle VM
    Mod Pathol; 2017 Sep; 30(9):1287-1298. PubMed ID: 28621318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of preoperative chemoradiotherapy on the immunological status of rectal cancer patients.
    Yasui K; Kondou R; Iizuka A; Miyata H; Tanaka E; Ashizawa T; Nagashima T; Ohshima K; Urakami K; Kusuhara M; Muramatsu K; Sugino T; Yamguchi K; Mori K; Harada H; Nishimura T; Kagawa H; Yamakawa Y; Hino H; Shiomi A; Akiyama Y
    J Radiat Res; 2020 Sep; 61(5):766-775. PubMed ID: 32672335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrative Molecular Characterization of Resistance to Neoadjuvant Chemoradiation in Rectal Cancer.
    Kamran SC; Lennerz JK; Margolis CA; Liu D; Reardon B; Wankowicz SA; Van Seventer EE; Tracy A; Wo JY; Carter SL; Willers H; Corcoran RB; Hong TS; Van Allen EM
    Clin Cancer Res; 2019 Sep; 25(18):5561-5571. PubMed ID: 31253631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stratification to Neoadjuvant Radiotherapy in Rectal Cancer by Regimen and Transcriptional Signatures.
    Mahmood U; Blake A; Rathee S; Samuel L; Murray G; Sebag-Montefiore D; Gollins S; West NP; Begum R; Bach SP; Richman SD; Quirke P; Redmond KL; Salto-Tellez M; Koelzer VH; Leedham SJ; Tomlinson I; Dunne PD; Buffa FM; ; Maughan TS; Domingo E
    Cancer Res Commun; 2024 Jul; 4(7):1765-1776. PubMed ID: 39023969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Akt activation and experimental pharmacological inhibition on responses to neoadjuvant chemoradiotherapy in rectal cancer.
    Koyama FC; Lopes Ramos CM; Ledesma F; Alves VAF; Fernandes JM; Vailati BB; São Julião GP; Habr-Gama A; Gama-Rodrigues J; Perez RO; Camargo AA
    Br J Surg; 2018 Jan; 105(2):e192-e203. PubMed ID: 29341150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenomic profiles associated with response to neoadjuvant chemoradiotherapy in patients with rectal cancer.
    Akiyoshi T; Tanaka N; Kiyotani K; Gotoh O; Yamamoto N; Oba K; Fukunaga Y; Ueno M; Mori S
    Br J Surg; 2019 Sep; 106(10):1381-1392. PubMed ID: 31197828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effects of Neoadjuvant Treatment on the Tumor Microenvironment in Rectal Cancer: Implications for Immune Activation and Therapy Response.
    Chen CC; Wu ML; Huang KC; Huang IP; Chung YL
    Clin Colorectal Cancer; 2020 Dec; 19(4):e164-e180. PubMed ID: 32387305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor microRNAs Identified by Small RNA Sequencing as Potential Response Predictors in Locally Advanced Rectal Cancer Patients Treated With Neoadjuvant Chemoradiotherapy.
    Machackova T; Trachtova K; Prochazka V; Grolich T; Farkasova M; Fiala L; Sefr R; Kiss I; Skrovina M; Dosoudil M; Berindan-Neagoe I; Svoboda M; Slaby O; Kala Z
    Cancer Genomics Proteomics; 2020; 17(3):249-257. PubMed ID: 32345666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histological grading based on poorly differentiated clusters is predictive of tumour response and clinical outcome in rectal carcinoma treated with neoadjuvant chemoradiotherapy.
    Reggiani Bonetti L; Lionti S; Domati F; Pagliani G; Mattioli E; Barresi V
    Histopathology; 2017 Sep; 71(3):393-405. PubMed ID: 28425130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microarray profiling of mononuclear peripheral blood cells identifies novel candidate genes related to chemoradiation response in rectal cancer.
    Palma P; Cuadros M; Conde-Muíño R; Olmedo C; Cano C; Segura-Jiménez I; Blanco A; Bueno P; Ferrón JA; Medina P
    PLoS One; 2013; 8(9):e74034. PubMed ID: 24040155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression profile is associated with chemoradiation resistance in rectal cancer.
    Gantt GA; Chen Y; Dejulius K; Mace AG; Barnholtz-Sloan J; Kalady MF
    Colorectal Dis; 2014 Jan; 16(1):57-66. PubMed ID: 24034224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early dynamic transcriptomic changes during preoperative radiotherapy in patients with rectal cancer: a feasibility study.
    Supiot S; Gouraud W; Campion L; Jezéquel P; Buecher B; Charrier J; Heymann MF; Mahé MA; Rio E; Chérel M
    World J Gastroenterol; 2013 Jun; 19(21):3249-54. PubMed ID: 23745026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High Expression of VSTM2L Induced Resistance to Chemoradiotherapy in Rectal Cancer through Downstream IL-4 Signaling.
    Liu H; Zhang Z; Zhen P; Zhou M
    J Immunol Res; 2021; 2021():6657012. PubMed ID: 33506057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting the response to preoperative radiation or chemoradiation by a microarray analysis of the gene expression profiles in rectal cancer.
    Akiyoshi T; Kobunai T; Watanabe T
    Surg Today; 2012 Aug; 42(8):713-9. PubMed ID: 22706722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression profiling of rectal tumors defines response to neoadjuvant treatment related genes.
    Palma P; Cano C; Conde-Muiño R; Comino A; Bueno P; Ferrón JA; Cuadros M
    PLoS One; 2014; 9(11):e112189. PubMed ID: 25380052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.